CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
An ALK inhibitor, AZD3463 improves the anticancer effects of rapamycin in breast cancer cells
Authors
C. Biray Avci
N. P. Ozates Ay
C. Gunduz
F. Sogutlu
Publication date
1 January 2019
Publisher
Nature Publishing Group
Abstract
52nd Conference of the European-Society-of-Human-Genetics (ESHG) -- JUN 15-18, 2019 -- Gothenburg, SWEDENAvci, Cigir Biray/0000-0001-8251-4520WOS: 000489313904061[No abstract available]European Soc Human Gene
Similar works
Full text
Available Versions
Ege University Institutional Repository
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:gcris.ege.edu.tr:11454/633...
Last time updated on 23/11/2023